SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Schmidt Peter T.) ;pers:(Lindberg Greger)"

Sökning: WFRF:(Schmidt Peter T.) > Lindberg Greger

  • Resultat 1-8 av 8
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Beyder, Arthur, et al. (författare)
  • Loss-of-Function of the Voltage-Gated Sodium Channel Na(V)1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome
  • 2014
  • Ingår i: Gastroenterology. - : Elsevier BV. - 0016-5085 .- 1528-0012. ; 146:7, s. 1659-1668
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND & AIMS: SCN5A encodes the a-subunit of the voltage-gated sodium channel Na(V)1.5. Many patients with cardiac arrhythmias caused by mutations in SCN5A also have symptoms of irritable bowel syndrome (IBS). We investigated whether patients with IBS have SCN5A variants that affect the function of Na(V)1.5. METHODS: We performed genotype analysis of SCN5A in 584 persons with IBS and 1380 without IBS (controls). Mutant forms of SCN5A were expressed in human embryonic kidney-293 cells, and functions were assessed by voltage clamp analysis. A genome-wide association study was analyzed for an association signal for the SCN5A gene, and replicated in 1745 patients in 4 independent cohorts of IBS patients and controls. RESULTS: Missense mutations were found in SCN5A in 13 of 584 patients (2.2%, probands). Diarrhea-predominant IBS was the most prevalent form of IBS in the overall study population (25%). However, a greater percentage of individuals with SCN5A mutations had constipation-predominant IBS (31%) than diarrhea-predominant IBS (10%; P < .05). Electrophysiologic analysis showed that 10 of 13 detected mutations disrupted Na(V)1.5 function (9 loss-of-function and 1 gain-of-function function). The p. A997T-Na(V)1.5 had the greatest effect in reducing Na(V)1.5 function. Incubation of cells that expressed this variant with mexiletine restored their sodium current and administration of mexiletine to 1 carrier of this mutation (who had constipation-predominant IBS) normalized their bowel habits. In the genome-wide association study and 4 replicated studies, the SCN5A locus was strongly associated with IBS. CONCLUSIONS: About 2% of patients with IBS carry mutations in SCN5A. Most of these are loss-of-function mutations that disrupt Na(V)1.5 channel function. These findings provide a new pathogenic mechanism for IBS and possible treatment options.
  •  
2.
  • Beyder, Arthur, et al. (författare)
  • Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
  • 2014
  • Ingår i: Gastroenterology. - : Elsevier BV. - 0016-5085 .- 1528-0012. ; 146:7
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND & AIMS: SCN5A encodes the α-subunit of the voltage-gated sodium channel NaV1.5. Many patients with cardiac arrhythmias caused by mutations in SCN5A also have symptoms of irritable bowel syndrome (IBS). We investigated whether patients with IBS have SCN5A variants that affect the function of NaV1.5.METHODS: We performed genotype analysis of SCN5A in 584 persons with IBS and 1380 without IBS (controls). Mutant forms of SCN5A were expressed in human embryonic kidney-293 cells, and functions were assessed by voltage clamp analysis. A genome-wide association study was analyzed for an association signal for the SCN5A gene, and replicated in 1745 patients in 4 independent cohorts of IBS patients and controls.RESULTS: Missense mutations were found in SCN5A in 13 of 584 patients (2.2%, probands). Diarrhea-predominant IBS was the most prevalent form of IBS in the overall study population (25%). However, a greater percentage of individuals with SCN5A mutations had constipation-predominant IBS (31%) than diarrhea-predominant IBS (10%; P < .05). Electrophysiologic analysis showed that 10 of 13 detected mutations disrupted NaV1.5 function (9 loss-of-function and 1 gain-of-function function). The p. A997T-NaV1.5 had the greatest effect in reducing NaV1.5 function. Incubation of cells that expressed this variant with mexiletine restored their sodium current and administration of mexiletine to 1 carrier of this mutation (who had constipation-predominant IBS) normalized their bowel habits. In the genome-wide association study and 4 replicated studies, the SCN5A locus was strongly associated with IBS.CONCLUSIONS: About 2% of patients with IBS carry mutations in SCN5A. Most of these are loss-of-function mutations that disrupt NaV1.5 channel function. These findings provide a new pathogenic mechanism for IBS and possible treatment options.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Karling, Pontus, et al. (författare)
  • Function and dysfunction of the colon and anorectum in adults: working team report of the Swedish Motility Group (SMoG).
  • 2009
  • Ingår i: Scandinavian journal of gastroenterology. - : Informa UK Limited. - 1502-7708 .- 0036-5521. ; 44:6, s. 646-60
  • Forskningsöversikt (refereegranskat)abstract
    • Symptoms of fecal incontinence and constipation are common in the general population. These can, however, be unreliably reported and are poorly discriminatory for underlying pathophysiology. Furthermore, both symptoms may coexist. In the elderly, fecal impaction always must be excluded. For patients with constipation, colon transit studies, anorectal manometry and defecography may help to identify patients with slow-transit constipation and/or pelvic floor dysfunction. The best documented medical treatments for constipation are the macrogols, lactulose and isphagula. Evolving drugs include lubiprostone, which enhances colonic secretion by activating chloride channels. Surgery is restricted for a highly selected group of patients with severe slow-transit constipation and for those with large rectoceles that demonstrably cause rectal evacuatory impairment. For patients with fecal incontinence that does not resolve on antidiarrheal treatment, functional and structural evaluation with anorectal manometry and endoanal ultrasound or magnetic resonance (MR) of the anal canal may help to guide management. Sacral nerve stimulation is a rapidly evolving alternative when other treatments such as biofeedback and direct sphincter repair have failed. Advances in understanding the pathophysiology as a guide to treatment of patients with constipation and fecal incontinence is a continuing important goal for translational research. The content of this article is a summary of presentations given by the authors at the Fourth Meeting of the Swedish Motility Group, held in Gothenburg in April 2007.
  •  
8.
  • Zucchelli, Marco, et al. (författare)
  • Association of TNFSF15 polymorphism with irritable bowel syndrome.
  • 2011
  • Ingår i: Gut. - London : BMJ. - 1468-3288 .- 0017-5749. ; 60:12, s. 1671-7
  • Tidskriftsartikel (refereegranskat)abstract
    • Irritable bowel syndrome (IBS) is the most common gastrointestinal disorder, affecting more than 10% of the general population worldwide. Although a genetic component is suspected, unambiguous susceptibility genes have so far not been identified. This study tested the hypothesis that genes contributing to epithelial barrier integrity, control of mucosal immune responses and interactions with bacteria in the gut are associated with IBS.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-8 av 8
Typ av publikation
tidskriftsartikel (7)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (5)
övrigt vetenskapligt/konstnärligt (3)
Författare/redaktör
Ohlsson, Bodil (8)
Karling, Pontus (8)
Schmidt, Peter T. (8)
D'Amato, Mauro (7)
Dlugosz, Aldona (7)
visa fler...
Talley, Nicholas J. (4)
Agréus, Lars (4)
Walter, Susanna (4)
Simrén, Magnus, 1966 (3)
Ek, Weronica E (3)
Beyder, Arthur (3)
Gazouli, Maria (3)
Nardone, Gerardo (3)
Cuomo, Rosario (3)
Usai-Satta, Paolo (3)
Galeazzi, Francesca (3)
Neri, Matteo (3)
Halfvarson, Jonas, 1 ... (2)
Andreasson, Anna (2)
Zucchelli, Marco (2)
Bresso, Francesca (2)
Assadi, Ghazaleh (2)
Bonfiglio, Ferdinand ... (2)
Ackerman, Michael J. (2)
Mazzone, Amelia (2)
Strege, Peter R. (2)
Tester, David J. (2)
Saito, Yuri A. (2)
Bernard, Cheryl E. (2)
Enders, Felicity T. (2)
Törnblom, Hans, 1966 (1)
Abrahamsson, Hasse, ... (1)
Sjövall, Henrik, 195 ... (1)
Burwinkel, Barbara (1)
Lambrechts, Diether (1)
Pedersen, Nancy L (1)
Hellström, Per M., 1 ... (1)
Hallböök, Olof (1)
Jonkers, Daisy (1)
Vermeire, Severine (1)
Daly, Mark J. (1)
Törkvist, Leif (1)
Kjellström, Lars (1)
Magnusson, Patrik (1)
Holliday, Elizabeth ... (1)
Li, Ling (1)
Mayer, Emeran A. (1)
Franke, Andre (1)
Sjölund, Kristina (1)
visa färre...
Lärosäte
Umeå universitet (6)
Lunds universitet (6)
Karolinska Institutet (6)
Göteborgs universitet (4)
Linköpings universitet (4)
Uppsala universitet (3)
visa fler...
Stockholms universitet (3)
Örebro universitet (2)
visa färre...
Språk
Engelska (8)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (7)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy